A carregar...
A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer
Epidermal growth factor receptor (EGFR) is commonly overexpressed in breast cancer and is associated with poor clinical outcomes; however, an increasing number of patients have shown a poor effective response to EGFR tyrosine kinase inhibitors (EGFR-TKI). Here, we found that AXL expression was posit...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5325414/ https://ncbi.nlm.nih.gov/pubmed/27590506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11737 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|